biostudies-literatureUnknown100(2)Weisinger JDirection Générale de l’offre de SoinsEuropean Union, TOLERATE MSCA ProjectDirection Générale de l'offre de SoinsFrench Ministry of HealthEuropean CommissionAmerican journal of hematology350-353https://www.ebi.ac.uk/biostudies/studies/S-EPMC11705199biostudies-literatureEfficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura.PMC11705199P120118; AOM12259101072729Laurent MYgal BClaire RBarbet CGabriel CClaire PNeel ASamir SWeisinger JPierre PSimon VDavis ROlivier FManon MFadlallah JJean-Francois ABerangere JFFrancois PGilles KBaylatry MTKanouni TPaul CJean-Michel HAntoine DLionel GVeronique FBJean-Michel RBertrand GTheresa KAnne CRBouzid RLuc-Matthieu FMiguel HNathalie PYahsou DAgnes VMarie MVirginie BPatricia ZBruno MAude SMoranne OAlain SVeyradier ACelia SPascale PProvot FFrench National Center for Thrombotic Microangiopathies (CNR‐MAT)Mario OURieu VCorre ECoppo PAlain WTarik KSteven GJoly BSAntoine NAzoulay EElie APoullin PFrederic PBerengere CRVeronique LGMohamed HMarjanovic ZJoly ACAmelie SJean-Philippe CDominique CfalseEfficacy and Safety of Obinutuzumab in Immune-Mediated Thrombotic Thrombocytopenic Purpura.2025-01-01T00:00:00Z2025 Feb2026-06-02T00:11:02.965Z2026-05-24T03:07:45.473ZS-EPMC117051993966845410.1002/ajh.27550